Loading...
UK Trademark — IPO
MyCite
Application UK00914200513 · Registered
Quick Facts
| Application Number | UK00914200513 |
| Status | Registered |
| Owner | Otsuka Pharmaceutical Co., Ltd. |
| Filed | 2015-06-05 |
| Registered | 2015-09-18 |
| Renewal Due | 2035-06-05 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Is this trademark active?
Yes. MyCite is currently a registered UK trademark, with renewal due on 2035-06-05. It is protected under UK intellectual property law and can be enforced against infringing uses.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 9 — Electrical & IT
Computer application software for mobile phones, tablets, portable electronic devices and handheld computers for use in collecting and storing patient data and medical information including drug ingestion information, pulse, heart rate, respiratory rate, body temperature, electric pressure in the body, human motion, human position or sleeping condition from a sensor attached to the patient's body, and for use in transmitting the patient data and medical information to database.
Class 10 — Medical Devices
Medical apparatus and instruments; medical diagnostic instruments; sensor apparatus for medical use in monitoring the vital signs of patients.
Timeline
- Filed: 2015-06-05
- Registered: 2015-09-18
- Renewal due: 2035-06-05
About This Trademark
'MyCite' is a registered trademark on the UK IPO register, owned by Otsuka Pharmaceutical Co., Ltd.. The application (UK00914200513) was filed on 5 June 2015 and registered on 18 September 2015. The registration is set to expire on 5 June 2035.
This mark is recorded under multiple classes: Class 9 (scientific, electrical & IT apparatus); Class 10 (medical & surgical apparatus).
The trademark is represented by Venner Shipley LLP.
Frequently Asked Questions
Who owns UK trademark UK00914200513 ('MyCite')?
UK trademark UK00914200513 for the mark 'MyCite' in Class 9, 10 is recorded on the UK IPO register as owned by Otsuka Pharmaceutical Co., Ltd.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00914200513 currently a registered trademark?
Yes — the UK IPO records UK trademark UK00914200513 for the mark 'MyCite' as registered.
Which Nice classes is UK trademark UK00914200513 registered under?
UK trademark UK00914200513 for the mark 'MyCite' is recorded in Class 9 (scientific, electrical & IT apparatus); Class 10 (medical & surgical apparatus). The filed specification reads: Class 9: Computer application software for mobile phones, tablets, portable electronic devices and handheld computers for use in collecting and storing patient data and medical information including drug ingestion information, pulse, heart rate, respiratory rate, body temperature, electric pressure in the body, huma…
When was UK trademark UK00914200513 filed?
UK trademark UK00914200513 for the mark 'MyCite' was filed at the UK IPO on 5 June 2015 and registered on 18 September 2015.
When does UK trademark UK00914200513 need to be renewed?
UK trademark UK00914200513 for the mark 'MyCite' is currently recorded as valid until 5 June 2035, at which point it will need to be renewed with the UK IPO to remain in force.
Who is the attorney of record for UK trademark UK00914200513?
Venner Shipley LLP is listed as the attorney / representative of record for UK trademark UK00914200513 for the mark 'MyCite' on the UK IPO register.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Cross-Register Filings
Trademarks matching "MyCite" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
US — United States (USPTO)
| Mark | Ref | Status | Filed |
|---|---|---|---|
| ABILIFY MYCITESame applicant | 99309131 | 686 | 2025-07-29 |
| RYSPARIS MYCITESame applicant | 79292719 | 700 | 2020-06-24 |
| RYSDERO MYCITESame applicant | 79292747 | 700 | 2020-06-24 |
| RYSDEO MYCITESame applicant | 79292766 | 700 | 2020-06-24 |
Similar names
| Mark | Ref | Status | Filed |
|---|---|---|---|
| MYCITIZENM+ | 99507887 | 630 | 2025-11-20 |
Australia — Australia (IP Australia)
| Mark | Ref | Status | Filed |
|---|---|---|---|
| MyCiteSame applicant | 2024137 | protected | 2019-07-18 |
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
United States (USPTO)
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
Australia (IP Australia)
Australian trademark data is supplied by IP Australia (via IPGOD / IP RAPID) under the Creative Commons Attribution 4.0 International licence.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.